Scientists identify potential drug candidates for deadly pediatric leukemia

Scientists at Sanford Burnham Prebys Medical Discovery Institute have shown that two existing drug candidates--JAK inhibitors and Mepron--hold potential as treatments for a deadly acute myeloid leukemia (AML) subtype that is more common in children.

Read more: https://www.eurekalert.org/pub_releases/2021-04/sbpm-sip041421.php